# Nandi Proteins

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nandi-proteins

- Industry: Food
- Headquarters: Edinburgh, UK
- Website: www.nandiproteins.com
- Total disclosed funding: $1.1M
- Latest round: Series B (Oct 30, 2014)
- Investors on record: 1

## About

Nandi Proteins Ltd specializes in developing innovative functional proteins to enhance food ingredients, addressing social, health, and environmental challenges in the food industry.Nandi Proteins Ltd, founded in 2001 and headquartered in Edinburgh, UK, focuses on enhancing the functionality of proteins for the food industry. The company has experienced a significant shift towards innovative protein solutions. The CEO, David Flower, leads the company, which has engaged in 5 deals, including a recent VENTURE DEBT round in September 2020, raising GBP 720,000. The total amount raised to date is GBP 1.01 mn.Nandi Proteins specializes in the development of functional proteins aimed at enhancing food ingredients. Their core offerings include innovative ingredients that replace traditional emulsifiers, fat, and egg whites, focusing on improving the functionality of whey protein, collagen, and various plant proteins. Their products are tailored for food manufacturers to create healthier formulations, particularly in baked goods and processed meats. Solutions like whey protein-based emulsifiers and collagen-derived fat replacers are utilized by notable brands in Europe and North America, driven by patented process control technology.In 2023, Nandi Proteins reported a revenue of GBP 62,196.80 with an EBITDA of GBP -647,632.40. Revenue is generated primarily through B2B transactions with food manufacturers and ingredient producers, by licensing their patented processes. Clients engage Nandi's proprietary technology and products to enhance their offerings, with revenue structures including direct sales and ongoing royalties.In September 2020, Nandi Proteins Ltd raised GBP 720,000 in venture debt funding from British Business Bank and Shackleton Ventures, with participation from returning investor Frontier IP Group plc. The funding will be utilized to advance technology and achieve technical and commercial milestones. Nandi aims to expand its product portfolio, targeting new markets, particularly in Europe and North America, and is focused on launching new functional proteins that cater to evolving food industry demands.

## Funding rounds

- Series B, Oct 30, 2014, $1.1M — Parkwalk Advisors

## Investors

- Parkwalk Advisors (https://capitalatlas.ai/funds/parkwalk-advisors) — Series B